Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Aurintricarboxylic acid (ATA) is an endonuclease inhibitor which has been shown to block apoptotic cell death. We have now demonstrated that ATA is also an inhibitor of the Ca(2+)-activated neutral protease (calpain), a class of cytosolic enzyme that may also be activated during apoptosis. The two major calpain isoforms (mu- and m-calpain) were both inhibited by ATA with IC50's of 22 microM and 10 microM, respectively. The autolysis of purified
mu-calpain
was prevented by ATA in a concentration-dependent manner. Using casein zymography, it was found that the inhibition of
mu-calpain
by ATA was reversible. Finally, in a fetal rat cerebrocortical culture model of excitotoxicity, pre- and post-treatment of ATA (50 microM) reduced N-methyl-D-aspartate (NMDA)-induced spectrin breakdown and neuronal death, while application of ATA concurrent to NMDA challenge alone had no effect. This pattern of protection could not be explained by simple NMDA receptor antagonism. We thus propose that the neuroprotective effect of ATA could be in part due to its ability to inhibit calpain.
Biochem
Mol
Biol Int 1995 Jun
PMID:Aurintricarboxylic acid is an inhibitor of mu- and m-calpain. 766 33
The activities of cathepsins B, L, and H increased by 3.0, 2.3, and 1.9 fold in differentiation of L6 myoblasts. Separating from the intrinsic inhibitor, both mu- and m-calpain activities also increased by 4.9 and 1.7 fold during differentiation. Calpeptin (10(-5)M), cell penetrating calpain inhibitor, blocked fusion of myoblast by 55% and increment of creatine phosphokinase (CPK) activity by 20.3% with inhibiting the activities of cathepsin L and
mu-calpain
. E-64(10(-4)M) did not block fusion of myoblasts but increment of CPK activity by 25.0% with inhibiting the activities of cathepsin L and B. Calpain may be involved in the process of myoblast fusion.
Biochem
Mol
Biol Int 1994 Mar
PMID:Role of intracellular proteases in differentiation of L6 myoblast cells. 803 18
In chicken, three calpain isozymes expressed ubiquitously, mu-, mu/m- and m-types, have been identified at the cDNA and/or protein level, but the complete sequence of the
mu-calpain
large subunit (microCL) and its small subunit (30K) remain to be determined. In this report, we isolated and identified cDNA clones for chicken microCL and 30K, uncovering all molecules of the chicken ubiquitous calpain system. The longest open reading frame of microCL encodes 715 amino acid residues (M(r) = 81,410). The deduced amino acid sequence is more similar to that of human microCL (82%) than that of chicken mCL (61.6%) and mu/mCL (70.6%). As for 30K, several cDNA clones were isolated, but a full length cDNA are not isolated, presumably because of a GC-rich sequence of the 5'-terminus. The longest open reading frame encodes 214 amino acid residues, showing significant similarity to mammalian 30Ks. Northern blot analysis of microCL and 30K mRNA shows ubiquitous expression in all chicken tissues examined. The results indicate that microCL and 30K are well conserved in both chicken and mammal, confirming that at least three independent ubiquitous calpain species exist in chicken.
Comp Biochem Physiol B Biochem
Mol
Biol 1997 Nov
PMID:Molecular cloning and characterization of cDNAs for the mu-type large subunit and the small subunit of chicken calpain. 946 68
Calpains, Ca(2+)-dependent neutral proteinases (microM and mM Ca(2+)-sensitive), and their endogenous inhibitor calpastatin were examined in rat brain. Specific activity of m-calpain exceeded almost 10 times that of
mu-calpain
, and the both isoforms of calpain together with calpastatin were mainly located in the soluble fraction of homogenate. Acute postdecapitative ischemia of 15 min duration resulted in a gradual, time-dependent decrease of total
mu-calpain
activity (to 60% of control values) and in the moderate elevation of calpastatin activity (by 28%). The decrease of total
mu-calpain
activity coincided with its remarkable increase (above 300% of control values) in particulate fraction. In the case of m-calpain, the only observed effect of ischemia was its redistribution and, as a consequence, the elevation of activity in particulate fraction. The accumulation of breakdown products, resulting from calpain-catalyzed proteolysis of fodrin (as revealed by Western blotting) indicated activation of calpain under ischemia. The findings suggest that this rapid activation involves partial enzyme translocation toward membranes, and is followed (at least in acute phase) by
mu-calpain
downregulation and increased calpastatin activity.
Mol
Chem Neuropathol 1998 Apr
PMID:Dual response of calpain to rat brain postdecapitative ischemia. 964 72
Presenilin 2 (PS2) is a gene responsible for the early-onset familial Alzheimer's disease (AD). PS2 mutations are considered to be closely related to the pathogenesis of AD. We screened for proteins that interact with PS2 to understand its pathological and physiological functions. Using the PS2 loop domain as the bait, the yeast two-hybrid system was used for screening, and
mu-calpain
was identified as a PS2 binding protein. In COS-1 cells, the interaction of PS2 with
mu-calpain
was confirmed by immunoprecipitation. These results suggested that PS2 and
mu-calpain
interact with each other, and might regulate each other's functions.
Int J
Mol
Med 1998 May
PMID:The presenilin 2 loop domain interacts with the mu-calpain C-terminal region. 985 98
Calpain I (
mu-calpain
) and II (m-calpain) are well known calcium-activated neutral cysteine proteases. Many reports have shown that activation of calpain is related to cataract formation, neuronal degeneration, blood clotting, ischemic injuries, muscular dystrophy and cornified cell envelope (CE) formation. Here, we report that insoluble CE formation was reduced after treatment with calpain I inhibitor (N-acetyl-leucyl-leucyl-norleucinal) on normal human epidermal keratinocytes (NHEK), whereas serine and thiol protease inhibitors had no effect on the reduction of CE. When NHEK cells were confluent, keratinocytes were treated with various concentrations (0.5 microM-0.5 mM) of calpain I inhibitor or serine and thiol protease inhibitors under calcium induced differentiation. Insoluble CE formation was reduced about 90% in the 50 microM calpain inhibitor I treated group by day 9 of culture, whereas insoluble CE was reduced only 10% in the same condition. Interestingly TGase activity was blocked by 90% in the 0.5 mM calpain inhibitor treated group within 72 h, whereas TGase activity was retained by 80% in the 0.5 mM serine protease inhibitor treated group at 7 day treatment. Therefore it can be suggested that cysteine protease calpains might be responsible for the activation of the TGase 1 enzyme to complete insoluble CE formation during epidermal differentiation.
Exp
Mol
Med 1998 Dec 31
PMID:Calpain inhibitors reduce the cornified cell envelope formation by inhibiting proteolytic processing of transglutaminase 1. 989 58
The effects of pressure on mu and m-calpain stability and specific activity have been examined. Activity and stability of these neutral calcium-dependent heterodimeric proteinases were studied using an in-house built bioreactor allowing on-line spectrophotometric monitoring with retention of pressure. Both isozymes were founded to be rather baro-sensitive with t1/2 at 1500 bar of 6 min and 11 min for mu and m-calpain respectively. Activity measurements under pressure showed a biphasic behavior for both proteinases with a slight activation for pressure up to 500 bar and 750 bar for m and
mu-calpain
respectively. Activation volume changes indicated that the proteolytic reaction was alternatively favored and disfavored by pressure due to catalytic step activation associated with enzyme-substrate binding step being continuously inhibited by pressure. Furthermore, autoproteolysis of calpain, a calcium dependent phenomenon was inhibited by application of pressure indicating that pressure inhibition of proteolytic activity could also be due to Ca2(+)-binding decrease under pressure. Implication of these results with catalytic mechanism of these heterodimeric proteinases is also discussed.
Biochem
Mol
Biol Int 1999 Jan
PMID:Pressure effects on proteolysis catalysed by calpain. 1009 42
Several mutations of presenilin (PS)-1, 2 result in early onset Alzheimer disease. Using the yeast two-hybrid system, the interaction between PS2 loop domain and the C-terminal region of
mu-calpain
was previously identified. Calpain is a calcium dependent-protease and there are two isoforms, m-calpain and
mu-calpain
, which differ in the calcium concentration required for activation. m-Calpain needs about 10(-3) M calcium ions, whereas
mu-calpain
about 10(-5) M. When PS and calpain were separately expressed in COS cells by cDNA transfection and then combined in vitro, or both were co-transfected to be co-expressed in vivo in COS cells, PS1 and PS2 reduced the casein proteolysis activity of m-calpain but not that of
mu-calpain
. Some of the PS mutations related to Alzheimer disease decreased this inhibitory activity. On the other hand, PS1 was cleaved by m-calpain and
mu-calpain
at a different site from those already reported (constitutive cleavage or alternative cleavage). These results suggest a regulatory function of presenilin on the calpain system.
Int J
Mol
Med 2000 Mar
PMID:Molecular interactions between presenilin and calpain: inhibition of m-calpain protease activity by presenilin-1, 2 and cleavage of presenilin-1 by m-, mu-calpain. 1067 67
Calcium-dependent proteinases or calpains were studied in fish muscle. Hydrophobic chromatography, followed by anion-exchange chromatography of the soluble fraction of sea bass white muscle proteins, resulted in three peaks of calcium-dependent protease activity at neutral pH (A, B and C). They are all neutral cysteine calcium-activated proteinases and can, therefore, be classified as calpain-like enzymes. From the Ca2+ concentration required for activity, A is a
mu-calpain
, and B and C are m-calpains. They share many properties with calpains from other vertebrate cells but differ in native mass, subunit composition, and the unusual numbers in which they are present. Their specific pattern of expression throughout the year could be of great importance to the resulting rate and extent of degradation of fish flesh after death.
Comp Biochem Physiol B Biochem
Mol
Biol 2000 Jan
PMID:Neutral calcium-activated proteases from European sea bass (Dicentrarchus labrax L.) muscle: polymorphism and biochemical studies. 1084 Jun 44
Conventional calpains are ubiquitous calcium-regulated cysteine proteases that have been implicated in cytoskeletal organization, cell proliferation, apoptosis, cell motility, and hemostasis. There are two forms of conventional calpains: the
mu-calpain
, or calpain I, which requires micromolar calcium for half-maximal activation, and the m-calpain, or calpain II, which functions at millimolar calcium concentrations. We evaluated the functional role of the 80-kDa catalytic subunit of
mu-calpain
by genetic inactivation using homologous recombination in embryonic stem cells. The
mu-calpain
-deficient mice are viable and fertile. The complete deficiency of
mu-calpain
causes significant reduction in platelet aggregation and clot retraction but surprisingly the mutant mice display normal bleeding times. No detectable differences were observed in the cleavage pattern and kinetics of calpain substrates such as the beta3 subunit of alphaIIbbeta3 integrin, talin, and ABP-280 (filamin). However,
mu-calpain
null platelets exhibit impaired tyrosine phosphorylation of several proteins including the beta3 subunit of alphaIIbbeta3 integrin, correlating with the agonist-induced reduction in platelet aggregation. These results provide the first direct evidence that
mu-calpain
is essential for normal platelet function, not by affecting the cleavage of cytoskeletal proteins but by potentially regulating the state of tyrosine phosphorylation of the platelet proteins.
Mol
Cell Biol 2001 Mar
PMID:Disruption of the mouse mu-calpain gene reveals an essential role in platelet function. 1123 54
1
2
3
4
5
6
Next >>